The goal of this program is to develop leadership and mentoring skills in diverse leaders at Life Science companies, enabling them to support, initiate, and/or lead diversity efforts at their respective companies.

Why is this important?

The Pistoia Alliance has created this online six weekly module program to bring together leaders from across the Pharmaceutical and the Life Science industries to network and learn how they, as leaders, can better support the D&I initiatives within their companies.

 

As collaboration, innovation and education is at the heart of the Pistoia Alliance we see this community as being essential to supporting both the internal and external focus of the Pharma and Life Science global community.

Program benefits

Network This program provides a unique opportunity to network online and offline with worldwide leaders across the life sciences industry.

Growth Though an action-oriented approach (role plays, scenarios, questions for “aha” moments), the participants become better prepared to overcome challenging situations for themselves and their team members.

Community Alumni are invited to different events to meet and network online and offline with past, current, and future D&I Leadership participants and other leaders from Pistoia Alliance network of members.

What will the project achieve?

This program will commence with a kick-off session followed by weekly training and networking sessions.

The participants will be guided in the discussions by an accredited trainer and coach that will help them increase their leadership skills with the support of the group participants and better understand how to support D&I initiatives from their leadership role.

 

Program Goals:

1. Promote diversity starting from the top executive roles*
2. Improve leaders’ understanding of the importance of D&I industry-wide
3. Raise awareness about different diversity aspects (e.g. neurodiversity) and how leaders can support D&I initiatives in their organizations
4. Develop leadership skills and increase executive presence at industry level

By the end, each leader will be equipped to support, diversity programs at their respective companies and will have a global community they can engage with for coaching, mentoring, for further discussion.

How will the project do this?

How we achieve the program goals:

1. Bringing together various industry leaders to discuss through practical examples how they can better support the D&I in their organizations
2. Building a community of D&I advocates by facilitating the networking between previous, current and future participants.
3. Encouraging the participants to share different perspectives and best practices, participate in role plays and scenarios.
4. Discussing through practical examples some actionable steps for supporting and improving D&I initiatives.
5. Peer mentoring
Learn more about our program stream for leaders of teams in life science who are interested in improving their leadership effectiveness in executive roles and augmenting their existing company programs to more effectively attract and retain talent.

Pricing and Dates

MEMBER STATUS PRICING
PA Members $1,500 USD Register Now
Non-Member Companies $1,995 USD Register Now

 

Three cohorts per annum starting:
  • February 12 – graduating March 28, 2024 – enrol here

  • April 15 – graduating May 30, 2024 – enrol here

  • September 9 – graduating October 31, 2024 – enrol here

Interested in enrolling?
Send an email to Diversity@PistoiaAlliance.org to learn more about our group packages for eight (8) or more employees.

 

If you are interested in helping to fund Pistoia Alliance’s Diversity & Inclusion in STEM Leadership program, please send an email to Diversity@PistoiaAlliance.org.

 

Alumni – Companies

Since 2022 we successfully onboarded in the program participants from 29 organizations including…Abbvie, Accenture, Algorithmiq, AstraZeneca, Bayer, Biogen, BLS, BMS, CCDC, Chemaxon, CSL, DeepMatter, Eli Lilly, Elsevier, Elucidata, Gilead, GSK, JnJ, Merck, MSD, Novartis, Novo Nordisk, Pfizer, Qubit Pharmaceuticals, Roche, Sanofi, Seagen, Takeda, Vertex).

The community of D&I supporters is growing with each new cohort onboarded.

 

**EU law – Gender Equality adopted in Nov 22.
By 2026, companies will need to have 40% of the underrepresented sex among non-executive directors or 33% among all directors.
https://ec.europa.eu/commission/presscorner/detail/en/statement_22_7074